Stocks to BUY, SELL or HOLD Today, April 15: ICICI Pru AMC, LG Electronics, Hero MotoCorp, Jindal SAW and others – Markets

Stocks to BUY, SELL or HOLD Today, April 15: ICICI Pru AMC, LG Electronics, Hero MotoCorp, Jindal SAW and others - Markets


Stocks to BUY, SELL or HOLD Today, April 15: The stock market today is expected to see strong activity as brokerages release fresh buy, sell, and hold stock recommendations for 2026 share price targets.

Key updates show mixed sentiment across sectors, including insurance, auto, pharma, FMCG, and manufacturing. Stocks like Hero MotoCorp, LG Electronics, Jindal SAW, Vishal Mega Mart, and Orkla India remain in the buy zone with upside potential, while Dr Reddy’s Laboratories carries a sell rating with downside risk. ICICI Prudential Life Insurance shows mixed views with multiple target prices.

Here’s a list of stocks to BUY, SELL or HOLD in today’s trading session:

ICICI Prudential Life Insurance Share Price Target 2026

Also Read: ICICI Pru Life Insurance Q4 Review: Brokerages flag margin strength, protection push; Growth concerns persist

ICICI Prudential AMC Share Price Target 2026

Here MotoCorp Share Price Target 2026

MOSL has maintained its Buy recommendation on Hero MotoCorp, with a target price of Rs 6,205. The brokerage noted that demand remained healthy during Q4, with a positive outlook going forward.

LG Electronics Share Price Target 2026

Nuvama has initiated coverage on LG Electronics with a Buy recommendation and a target price of Rs 1,870. The brokerage highlighted the company’s strong leadership position across key product categories, including washing machines, refrigerators, televisions, and air conditioners, which together contribute the majority of its revenues.

Jindal SAW Share Price Target 2026

Elara Capital has initiated coverage on Jindal SAW with a Buy recommendation and a target price of Rs 280.

Elara Capital has initiated coverage on Vishal Mega Mart with a Buy recommendation and a target price of Rs 130.

Dr Reddy’s Laboratories Share Price Target 2026

Citi has maintained its Sell rating on Dr Reddy’s Laboratories, with a target price of Rs 1,070, implying a potential downside of approximately 13 per cent from the current market price.

Orkla India Share Price Target 2026

DAM Capital has initiated coverage on Orkla India with a Buy recommendation and a target price of Rs 780.

(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money-related decisions.)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *